Citation: | LIU Hongyuan. Influence of serum Cysatin C level on short-term prognosis of patients with ischemic heart failure[J]. Journal of Clinical Medicine in Practice, 2014, (13): 122-123,127. DOI: 10.7619/jcmp.201413041 |
胡秀全. 连续性血液净化治疗重症心力衰竭合并肾衰竭患者 18 例疗效观察 [J]. 实用临床医药杂志, 2013, (14):71.
|
冯绍明, 龚英峰, 裴荣光. 血清胱抑素 C 与早期高血压肾损害的相关性研究 [J]. 实用临床医药杂志, 2013, (13):121.
|
陈灏珠. 心脏病学 [M]. 北京:人民卫生出版社, 2003.407.
|
中华医学会心血管病学分会. 慢性收缩性心力衰竭治疗建议 [J]. 中华心血管病杂志, 2002(1):7.
|
SHLIPAK M G, SARNAK M J, KATZ R. Cystatin C and the risk of death and cardiovascular events among el-derly persons [J]. New England Journal of Medicine, 2005, (20):2049.
|
Sarnak M J, Katz R, Stehman-Breen C O. Cystatin C concentration as a risk factor for heart failure in older adults [J]. ANNALS OF INTERNAL MEDICINE, 2005(7):497.
|
FILLER G, BOKENKAMP A, HOFMANN W. Cys-tatin C as a marker of GFR history, indications, and future research [J]. CLINICAL BIOCHEMISTRY, 2005(1):1.
|
王超权. 慢性心力衰竭患者血胱抑素浓度变化及临床意义 [J]. 现代实用医学, 2010(2):193.
|
Moran A, Kata R, Smith N L. Cystatin C concentra-tion as a predictor of systolic and diastolic heart failure [J]. Journal of Cardiac failure, 2008(1):19.
|
卓奕春, 陈雪丽, 周子杰. 血清胱抑素 C 联合尿微量白蛋白检测在糖尿病肾病早期诊断中的应用价值 [J]. 中国医学创新, 2012, (12):85.
|